How to find an FDA product code for a medical device
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Medical-device intelligence
FDA product code QDK: Integrated Continuous Glucose Monitoring System For Non-Intensive Diabetes Management. View classification details, related manufacturers, 510(k) clearances, and recall records.
An integrated continuous glucose monitoring system for non-intensive diabetes management is intended to replace finger stick blood glucose testing for diabetes treatment decisions in persons with diabetes who do not have significant risk of severe hypoglycemia. The device also aids in the detection of episodes of hyperglycemia and hypoglycemia, facilitating long-term therapy adjustments. The device is also intended to autonomously communicate with digitally connected devices. The device can be used alone or in conjunction with these digitally connected devices or services for the purpose of managing diabetes.Explore clinical chemistry records →
4 clearance records and 0 recall records in the covered releases, across 1 source company names and 1 product codes. Dated history runs from Oct 26, 2018 to Aug 17, 2021.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Code and FDA device name | Clearances | Recalls |
|---|---|---|
| QDK · Integrated Continuous Glucose Monitoring System For Non-Intensive Diabetes Management | 4 | 0 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| Dexcom G6 Glucose Program Continuous Glucose Monitoring (CGM) SystemK203089 · QDK | Dexcom, Inc. | 510(k) | Aug 17, 2021FDA decision date |
| Dexcom G6 Glucose Program Continuous Glucose Monitoring (CGM) SystemK193642 · QDK | Dexcom, Inc. | 510(k) | Jan 29, 2020FDA decision date |
| Dexcom G6 Glucose Program Continuous Glucose Monitoring (GCM) SystemK192787 · QDK | Dexcom, Inc. | 510(k) | Oct 25, 2019FDA decision date |
| Dexcom G6 Glucose Program Continuous Glucose Monitoring SystemK182041 · QDK | Dexcom, Inc. | 510(k) | Oct 26, 2018FDA decision date |
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Understand the K number, applicant, decision date, product code, and limits of the public clearance record.
Read the guide →FDA dataset:
Last successful check: Nov 21, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 21, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 21, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.